Material Information or Facts regarding the Postponement to the Proposed Capital Increase with Pre-emptive Rights II
Referring to Financial Service Authority (Otoritas Jasa Keuangan – “OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Information or Facts by Issuer or Public Company as partially amended by OJK Regulation No. 45 of 2024 on the Development and Strengthening of Issuers and Public Companies (“POJK 31/2015”) and Annex to the Board of Directors’ Decree of PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 on Amendments to Regulation No. I-E on the Information Submission Obligation, we, PT Pyridam Farma Tbk (the “Company”) hereby inform the following material information:
a. Date of Occurrence
June 11th, 2026
b. Type of Material Information or Fact
The Postponement to the Proposed Capital Increase with Pre-emptive Rights II
c. Details of Material Information or Fact
In relation to the proposed Capital Increase with Pre-emptive Rights II of the Company (Rights Issue II), the Company hereby announces the postponement of the implementation of the Rights Issue II. This decision was made after taking into consideration the current capital market and macroeconomic conditions, which are deemed not yet conducive to support the execution of the Rights Issue II. The Company will continue to monitor market developments and will reassess the implementation of the Rights Issue II at a more appropriate time once market conditions become more stable and conducive.
d. Impact of the Material Information or Fact
The postponement of the Rights Issue II does not have any material adverse impact on the operations, legal matters, financial condition, or business continuity of the Company.
Similar information is also submitted by the Company through IDX’s Website and reported to the OJK.
Jakarta, June 11th, 2026
PT Pyridam Farma Tbk
Corporate Secretary